Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

ClinicalTrials.gov ID: NCT01426269

Public ClinicalTrials.gov record NCT01426269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea® and MetroGel® 1% in Adults With Rosacea

Study identification

NCT ID
NCT01426269
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Galderma R&D
Industry
Enrollment
235 participants

Conditions and interventions

Conditions

Interventions

  • Doxycycline Drug
  • Metronidazole Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Jul 31, 2022

2011 – 2013

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
ATS Clinical Research Santa Monica California 90404
Dadeland Dermatology Coral Gables Florida 33134
Melissa L. F. Knuckles M.D., P.S.C. Corbin Kentucky 40701
Dermatology Specialists Research Louisville Kentucky 40202
Melissa L. F. Knuckles M.D., P.S.C. Richmond Kentucky 40475
The Maryland Laser, Skin, and Vein Institute, LLC Hunt Valley Maryland 21030
Grekin Skin Institute Warren Michigan 48088
Hilary Baldwin Brooklyn New York 11201
The Center for Dermatology at Linden Oaks Rochester New York 14625
Brodell Medical, Inc. Warren Ohio 44483
Center for Dermatology and Laser Surgery Portland Oregon 97225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01426269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01426269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →